Skip to main content
Clinical Trials/NCT02082301
NCT02082301
Completed
Not Applicable

Oral Glucose Tolerance Testing After Gestational Diabetes

MetroHealth Medical Center2 sites in 1 country118 target enrollmentOctober 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
MetroHealth Medical Center
Enrollment
118
Locations
2
Primary Endpoint
Primary outcome: sensitivity of immediate post partum screen
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.

Registry
clinicaltrials.gov
Start Date
October 2012
End Date
December 31, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ted Waters

Principal Investigator

MetroHealth Medical Center

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancy
  • Gestational diabetes

Exclusion Criteria

  • Multiple gestations
  • pre-pregnancy diabetes

Outcomes

Primary Outcomes

Primary outcome: sensitivity of immediate post partum screen

Time Frame: Immediate post partum

2 hour fasting 75g OGTT immediately post partum. This is compared to a traditional 6 week post partum 75g OGTT for the sensitivity, positive and negative predictive value of the immediate post partum test

Secondary Outcomes

  • Secondary outcome: physiology(3 time points: antepatum, immediate postpartum, 6 weeks post partum)

Study Sites (2)

Loading locations...

Similar Trials